News

Ministry of Health Refutes Allegations of Delays in Drug Registration Process

Port-of-Spain, December 16, 2024: The Ministry of Health (MOH) notes recent statements on the role of the Chemistry Food and Drug Division (CFDD) as it relates to the drug registration process. It is regrettable that this process, which is primarily aimed at protecting the nation’s health by ensuring that drugs approved for sale and consumption in Trinidad and Tobago are safe, effective and meet international regulatory standards, is now being misrepresented.

Share

Tags

Public Advisory on Hand, Foot and Mouth Disease

Port-of-Spain, December 13, 2024: The Ministry of Health wishes to advise citizens that a few suspected cases of Hand, Foot and Mouth Disease (HFMD) have recently been reported, and though it does not pose as a public health threat, persons should be vigilant in protecting themselves and their children from the disease.

The symptoms of HFMD are:

·         fever

·         loss of appetite

Share

Tags

Arboviral Diseases Update: Mayaro and Oropouche Viruses

Port of Spain, December 9th, 2024: The Ministry of Health is closely monitoring the emergence of the Mayaro and Oropouche viruses, two tropical diseases that pose potential health risks to the population of Trinidad and Tobago and the wider Caribbean. 

These arboviral diseases are spread primarily by the Aedes aegypti, Culex mosquitoes, and midge insect flies.

Share

Tags

Voluntary Recall of Paracodeine - Tablets

Port of Spain, November 12, 2024: The Ministry of Health (MoH), via its Drug Inspectorate advises of the voluntary recall of Paracodeine Tablets, batch number KA23227, distributed in the Trinidad market.

The recall issued by Cipla Limited, the manufacturer of the product, is as a result of
an observed “Out of Specification” (OOS) result for the codeine content found during stability testing, conducted at the twelve (12) month interval under standard conditions.

Share

Tags

Voluntary Recall of Apo-Amitriptyline Tablets USP- 10mg and 25mg

Port of Spain, October 24, 2024: The Ministry of Health (MoH), via its Chemistry, Food and Drugs Division advises of the voluntary recall of 26 lots of "Apo­ Amitriptyline 10mg and 25mg Tablets.

The recall issued by Apotex Incorporated, the manufacturer of the product, is as a result of exceeded limits of N-Nitroso Nortriptyline (NNORT), which was found in three (3) lots of the drug Apo-Amitriptyline. The additional 23 lots were recalled by the manufacturer as a measure of caution.

Share

Tags

Ministry of Health Receives Vaccine Safety Net Membership from WHO

Port of Spain, October 3, 2024: The Ministry of Health was recently verified as an official website for reliable vaccine safety information from the World Health Organization’s (WHO) Vaccine Safety Net (VSN) expansion project, making Trinidad and Tobago the first country in the Caribbean region to attain VSN membership.

Share

Tags

Ministry of Health launches Toll Free NCD Hotline

Port of Spain, September 2, 2024: The Ministry of Health is pleased to announce a new 24-hour hotline for Non-Communicable Diseases (NCDs). This free service offers medical advice and support for individuals who use home blood pressure or blood glucose monitors and have health-related questions, concerns about abnormal readings or any other NCD related issues.  This new service was formally launched in August, 2024.

Share

Tags